Effect of N -methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of N
-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide
Authors
Keywords
-
Journal
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
Volume 60, Issue 9, Pages 401-409
Publisher
Wiley
Online
2017-04-22
DOI
10.1002/jlcr.3516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide
- (2016) Jinfang Jiang et al. Drug Design Development and Therapy
- Clinical Pharmacokinetic Studies of Enzalutamide
- (2015) Jacqueline A. Gibbons et al. CLINICAL PHARMACOKINETICS
- Discovery and Development of Galeterone (TOK-001 or VN/124-1) for the Treatment of All Stages of Prostate Cancer
- (2015) Vincent C. O. Njar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes
- (2014) Ge Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer
- (2013) Mark Sanford DRUGS
- The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer
- (2012) Kevin D. Courtney et al. CURRENT OPINION IN ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
- (2011) Nicholas A. Meanwell JOURNAL OF MEDICINAL CHEMISTRY
- The changing therapeutic landscape of castration-resistant prostate cancer
- (2011) Timothy A. Yap et al. Nature Reviews Clinical Oncology
- Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
- (2010) Michael E. Jung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?
- (2009) Gerhardt Attard et al. CANCER CELL
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Targeting the androgen receptor pathway in prostate cancer
- (2008) Yu Chen et al. CURRENT OPINION IN PHARMACOLOGY
- Androgen receptor: role and novel therapeutic prospects in prostate cancer
- (2008) Mary-Ellen Taplin Expert Review of Anticancer Therapy
- International epidemiology of prostate cancer: Geographical distribution and secular trends
- (2008) Peter D. Baade et al. MOLECULAR NUTRITION & FOOD RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started